NCT06649500 Identify the Most Effective Rehabilitation Method Between a Treatment with a Sensorized Treadmill (Walker View) and a Treatment with Conventional Group Therapy in Balance Disorders and the Use of Artificial Intelligence to Identify Predictive Indices to Prevent Falls and Diagnose Promptly the Risk
| NCT ID | NCT06649500 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Campus Bio-Medico |
| Condition | Balance Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 108 participants |
| Start Date | 2024-12-04 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 108 participants in total. It began in 2024-12-04 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Falls in the elderly are one of the main sources of disability and hospitalization, with a significant impact on quality of life and social and healthcare costs. Falls represent a significant health concern for people over 60 years old. Numerous studies have shown that falls cause serious health consequences. Around 30% of people over the age of 60 experience a fall during the year. According to the impact falls have, the investigators decided to analyze the effectiveness of training on a Walker View sensorized treadmill, with the possibility of exercises for coordination and balance, compared to training with a conventional group therapy, in order to understand the best training to reduce the risk of falling and observe the possible improvements in daily life activities. So the study aims to identify the most effective rehabilitation method between a treatment with a sensorized treadmill (Walker View) and a conventional group therapy in balance disorders. The study also aims to identify predictive indices, with the use of Artificial Intelligence, that can contribute to the prevention and diagnosis of balance disorders in a short time and prevent falls in the elderly.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 65 years * Consent to participate in the study * Positive history of balance disorders * Absence of cognitive deficits (MMSE ≥ 24) * Tinetti \< 25 Exclusion Criteria: * Clinical pictures associated with musculoskeletal, cardiovascular, cerebrovascular, neuro-psychic problems and post-surgical outcomes that make the planned evaluation tests unfeasible. * Inability to carry out a walking test. * History of more than one fall in the last six months. * Subjects who have not expressed informed consent to participate in the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06649500 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Balance Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06649500 currently recruiting?
Yes, NCT06649500 is actively recruiting participants. Contact the research team at f.bressi@policlinicocampus.it for enrollment information.
Where is the NCT06649500 trial being conducted?
This trial is being conducted at Rome, Italy.
Who is sponsoring the NCT06649500 clinical trial?
NCT06649500 is sponsored by Fondazione Policlinico Universitario Campus Bio-Medico. The trial plans to enroll 108 participants.